Jyong Biotech Ltd. MENS
NasdaqSmall CapHealthcare
13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Top Institutional Holders
as of Q2 2026$538.9K+0.6%
$142.6K+7.2%
$104.0K+328.5%
$60.2KNew
$47.4KNew
$25.0K-8.1%
$23.2KNew
$12.7K-3.0%
$12.3K+14.3%
$11.8K-5.3%
$8.4K-89.2%
$7.0K-12.2%
$5.6K+44.1%
$5.2K-10.3%
$3.2K-7.0%
$2.2K-90.9%
$427-56.4%
Reading the latest SEC filing…